Status:
RECRUITING
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
Lead Sponsor:
Centre Oscar Lambret
Conditions:
Smoking Cessation
Nicotine Addiction
Eligibility:
All Genders
18+ years
Brief Summary
The TABAC STOP ORL POUMON study aims to evaluate the factors influencing long-term smoking cessation in patients with head and neck cancer (HNC) or lung cancer undergoing radiotherapy or chemoradiothe...
Detailed Description
The TABAC STOP ORL POUMON study is a prospective, single-center observational study aiming to understand factors influencing long-term smoking cessation in patients treated for head and neck or lung c...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Patient aged 18 years or older
- Diagnosed with head and neck cancer or lung cancer
- Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy
- Current or former smoker
- Patient covered by a social security scheme
- Patient informed and having given consent for data collection
- Patients with human papillomavirus (HPV) may also be included
- Exclusion Criteria :
- Patient receiving palliative treatment
- Patient under guardianship or curatorship
- Study Exit Criteria :
- \- Protocol-defined exit : After the 12-month consultation
- Early exit :
- Withdrawal of consent for data collection
- Death of the patient
Exclusion
Key Trial Info
Start Date :
March 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06910566
Start Date
March 28 2022
End Date
December 1 2025
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Oscar Lambret
Lille, France, 59020